WHO ICTRP trial
SGLT2i, ARNi And Diuretic Use In Patients With Heart Failure
CTRI/2024/07/071466 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2024/07/071466 |
|---|---|
| Public title | SGLT2i, ARNi And Diuretic Use In Patients With Heart Failure |
| Scientific title | SGLT2i, ARNi And Diuretic Use In Patients With Heart Failure With Preserved And Reduced Ejection Fraction - NIL |
| Primary sponsor | NGSM Institute of Pharmaceutical Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: I509- Heart failure, unspecified |
| Interventions | Intervention1: NIL: NIL Control Intervention1: NIL: NIL |
| Registration date | Jul 29, 2024 |
| Target size | 103 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: